Ohki Healthcare Holdings Co.,Ltd. (3417.T)
JPY 796.0
(0.63%)
JPY 796.0
(0.63%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 3.81 Billion JPY | -32.03% |
| 2022 | 3.58 Billion JPY | 78.19% |
| 2021 | 1.94 Billion JPY | -55.36% |
| 2020 | 4.49 Billion JPY | 22.18% |
| 2019 | 3.76 Billion JPY | 3.77% |
| 2018 | 3.45 Billion JPY | -4.67% |
| 2017 | 3.64 Billion JPY | 41.04% |
| 2016 | 1.74 Billion JPY | -24.51% |
| 2015 | 1.98 Billion JPY | 29.27% |
| 2014 | 1.04 Billion JPY | -25.64% |
| 2013 | 1.94 Billion JPY | 12.81% |
| 2012 | 1.67 Billion JPY | 2.36% |
| 2011 | 1.48 Billion JPY | -10.63% |
| 2010 | 2.1 Billion JPY | 6.76% |
| 2009 | 804 Million JPY | 19.88% |
| 2008 | 954 Million JPY | 27.01% |
| 2007 | 901.21 Million JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 382.25 Million JPY | -33.68% |
| 2023 Q3 | 539 Million JPY | -57.09% |
| 2023 FY | - JPY | -32.03% |
| 2023 Q1 | 543 Million JPY | -51.69% |
| 2023 Q2 | 1.25 Billion JPY | 131.31% |
| 2023 Q4 | 738 Million JPY | 36.92% |
| 2022 Q1 | 494 Million JPY | 119.56% |
| 2022 FY | - JPY | 78.19% |
| 2022 Q4 | 1.12 Billion JPY | 37.41% |
| 2022 Q3 | 818 Million JPY | 8.92% |
| 2022 Q2 | 751 Million JPY | 52.02% |
| 2021 Q4 | 225 Million JPY | -24.24% |
| 2021 Q2 | 717 Million JPY | 89.18% |
| 2021 Q3 | 297 Million JPY | -58.58% |
| 2021 Q1 | 379 Million JPY | 70.72% |
| 2021 FY | - JPY | -55.36% |
| 2020 FY | - JPY | 22.18% |
| 2020 Q3 | 1.06 Billion JPY | -41.27% |
| 2020 Q2 | 1.81 Billion JPY | 63.66% |
| 2020 Q1 | 1.1 Billion JPY | 2.21% |
| 2020 Q4 | 222 Million JPY | -79.17% |
| 2019 Q4 | 1.08 Billion JPY | 80.83% |
| 2019 Q2 | 1.11 Billion JPY | 144.93% |
| 2019 FY | - JPY | 3.77% |
| 2019 Q1 | 454 Million JPY | -47.51% |
| 2019 Q3 | 600 Million JPY | -46.04% |
| 2018 FY | - JPY | -4.67% |
| 2018 Q3 | 728 Million JPY | -32.9% |
| 2018 Q1 | 483 Million JPY | -58.61% |
| 2018 Q4 | 865 Million JPY | 18.82% |
| 2018 Q2 | 1.08 Billion JPY | 124.64% |
| 2017 Q1 | 383 Million JPY | -83.04% |
| 2017 Q2 | 1.13 Billion JPY | 195.82% |
| 2017 FY | - JPY | 41.04% |
| 2017 Q3 | 657 Million JPY | -42.01% |
| 2017 Q4 | 1.16 Billion JPY | 77.63% |
| 2016 Q2 | 653 Million JPY | 149.24% |
| 2016 FY | - JPY | -24.51% |
| 2016 Q4 | 2.25 Billion JPY | 218.48% |
| 2016 Q3 | 709 Million JPY | 8.58% |
| 2016 Q1 | 262 Million JPY | -88.19% |
| 2015 Q1 | -73 Million JPY | -103.92% |
| 2015 FY | - JPY | 29.27% |
| 2015 Q4 | 2.21 Billion JPY | 0.0% |
| 2014 Q4 | 1.86 Billion JPY | 20600.0% |
| 2014 FY | - JPY | -25.64% |
| 2014 Q3 | 9 Million JPY | -98.26% |
| 2014 Q2 | 517 Million JPY | 674.44% |
| 2014 Q1 | -90 Million JPY | -104.33% |
| 2013 Q2 | 554 Million JPY | 350.41% |
| 2013 Q3 | 540 Million JPY | -2.53% |
| 2013 Q4 | 2.07 Billion JPY | 284.63% |
| 2013 FY | - JPY | 12.81% |
| 2013 Q1 | 123 Million JPY | -93.84% |
| 2012 Q3 | 547 Million JPY | 174.87% |
| 2012 Q4 | 1.99 Billion JPY | 265.27% |
| 2012 Q2 | 199 Million JPY | -1.0% |
| 2012 FY | - JPY | 2.36% |
| 2012 Q1 | 201 Million JPY | -88.27% |
| 2011 Q2 | 452 Million JPY | 70.57% |
| 2011 FY | - JPY | -10.63% |
| 2011 Q1 | 265 Million JPY | -84.39% |
| 2011 Q3 | 393 Million JPY | -13.05% |
| 2011 Q4 | 1.71 Billion JPY | 335.88% |
| 2010 Q4 | 1.69 Billion JPY | 188.78% |
| 2010 FY | - JPY | 6.76% |
| 2010 Q3 | 588 Million JPY | -1.34% |
| 2010 Q2 | 596 Million JPY | 4.75% |
| 2010 Q1 | 569 Million JPY | -59.36% |
| 2009 Q3 | 768 Million JPY | 81.99% |
| 2009 Q4 | 1.4 Billion JPY | 82.29% |
| 2009 Q1 | 742 Million JPY | -59.58% |
| 2009 FY | - JPY | 19.88% |
| 2009 Q2 | 422 Million JPY | -43.13% |
| 2008 Q2 | 202 Million JPY | 0.0% |
| 2008 Q3 | 372 Million JPY | 84.16% |
| 2008 Q4 | 1.83 Billion JPY | 393.49% |
| 2008 FY | - JPY | 27.01% |
| 2007 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| HEARTSEED INC | -1.44 Billion JPY | 363.488% |
| Cawachi Limited | 11.85 Billion JPY | 67.803% |
| Pharmarise Holdings Corporation | 2.08 Billion JPY | -82.934% |
| Qol Holdings Co., Ltd. | 14.21 Billion JPY | 73.148% |
| MatsukiyoCocokara & Co. | 98.01 Billion JPY | 96.107% |
| Welcia Holdings Co., Ltd. | 67.62 Billion JPY | 94.357% |
| Create SD Holdings Co., Ltd. | 24.34 Billion JPY | 84.327% |
| NIHON CHOUZAI Co.,Ltd. | 14.65 Billion JPY | 73.961% |
| COSMOS Pharmaceutical Corporation | 51.42 Billion JPY | 92.58% |
| Tsuruha Holdings Inc. | 67.2 Billion JPY | 94.322% |
| Satudora Holdings Co.,Ltd. | 2.71 Billion JPY | -40.708% |
| Kusuri No Aoki Holdings Co., Ltd. | 30.64 Billion JPY | 87.546% |
| Medical System Network Co., Ltd. | 6.99 Billion JPY | 45.455% |
| Shinnihonseiyaku Co., Ltd. | 4.18 Billion JPY | 8.883% |
| Sugi Holdings Co.,Ltd. | 50.74 Billion JPY | 92.48% |
| YAKUODO HOLDINGS Co., Ltd. | 8.16 Billion JPY | 53.252% |
| Astena Holdings Co., Ltd. | 4.17 Billion JPY | 8.538% |
| Genky DrugStores Co., Ltd. | 14.47 Billion JPY | 73.635% |
| Ain Holdings Inc. | 31.22 Billion JPY | 87.778% |
| Sundrug Co.,Ltd. | 56.23 Billion JPY | 93.215% |